EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michel, V.
Right arrow Articles by Bakovic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michel, V.
Right arrow Articles by Bakovic, M.
Experimental Biology and Medicine 231:490-504 (2006)
© 2006 Society for Experimental Biology and Medicine


MINIREVIEW

Choline Transport for Phospholipid Synthesis

Vera Michel*, Zongfei Yuan*, Shobha Ramsubir{dagger} and Marica Bakovic*,1

* Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada N1G 2W1; and {dagger} Ontario Cancer Institute, Division of Stem Cell and Differentiation, University Health Network, Toronto, Ontario, Canada M5G 2M1

To whom requests for reprints should be addressed at 1 Animal Science and Nutrition Building, Rm. 346, University of Guelph, Guelph, Ontario, Canada N1G 2W1. E-mail: mbakovic{at}uoguelph.ca

Choline is an essential nutrient for all cells because it plays a role in the synthesis of the membrane phospholipid components of the cell membranes, as a methyl-group donor in methionine metabolism as well as in the synthesis of the neurotransmitter acetylcholine. Choline deficiency affects the expression of genes involved in cell proliferation, differentiation, and apoptosis, and it has been associated with liver dysfunction and cancer. Abnormal choline transport and metabolism have been implicated in a number of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Therefore, the study of choline transport and the characteristics of choline transporters are of central importance to understanding the mechanisms that underlie membrane integrity and cell signaling in such disorders. Kinetic studies with radiolabeled choline and inhibitors distinguish three systems for choline transport: (i) low-affinity facilitated diffusion, (ii) high-affinity, Na+-dependent transport, and (iii) intermediate-affinity, Na+-independent transport. It is only recently, however, that the proteins having transport characteristics of at least one of these systems have been identified. They include (i) polyspecific organic cation transporters (OCTs) with low affinity for choline, (ii) high-affinity choline transporters (CHT1s), and (iii) intermediate-affinity choline transporter-like (CTL1) proteins. CHT1 and CTL1 but not OCT transporters are selectively inhibited with hemicholinium-3 and essentially display characteristics of specialized transporters for targeted choline metabolism. CHT1 is abundant in neurons and almost exclusively supplies choline for acetyl-choline synthesis. The focus here is more on newly-discovered CTL1 choline transporters. They are expressed in different organisms and cell types, apparently not for the biosynthesis of acetylcholine but for the production of the most abundant metabolite of choline, the membrane lipid phosphatidylcholine.

Key Words: choline • phospholipids • choline transport • CTL1




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Dahlin, J. Royall, J. G. Hohmann, and J. Wang
Expression Profiling of the Solute Carrier Gene Family in the Mouse Brain
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 558 - 570.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. von Forstner, J.-H. Egberts, O. Ammerpohl, D. Niedzielska, R. Buchert, P. Mikecz, U. Schumacher, K. Peldschus, G. Adam, C. Pilarsky, et al.
Gene Expression Patterns and Tumor Uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an Orthotopic Mouse Xenotransplantation Model of Pancreatic Cancer
J. Nucl. Med., August 1, 2008; 49(8): 1362 - 1370.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Plathow and W. A. Weber
Tumor Cell Metabolism Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A. Orlacchio, F. Bolacchi, M. Cadioli, A. Bergamini, V. Cozzolino, M. Angelico, and G. Simonetti
Evaluation of the Severity of Chronic Hepatitis C with 3-T1H-MR Spectroscopy
Am. J. Roentgenol., May 1, 2008; 190(5): 1331 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Signore, P. M. Ueland, J. Troendle, and J. L Mills
Choline concentrations in human maternal and cord blood and intelligence at 5 y of age
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 896 - 902.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Wu, C. Aoyama, S. G. Young, and D. E. Vance
Early Embryonic Lethality Caused by Disruption of the Gene for Choline Kinase {alpha}, the First Enzyme in Phosphatidylcholine Biosynthesis
J. Biol. Chem., January 18, 2008; 283(3): 1456 - 1462.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.